United States · FDA National Drug Code directory
Desvenlafaxine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46708-541_162ec8ed-f695-4db2-badf-4afb6b9e1cba
- Product NDC
- 46708-541
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Desvenlafaxine Succinate
- Labeler
- Alembic Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170301
- Source listing expiry
- 20261231
Source-listed ingredients
- DESVENLAFAXINE SUCCINATE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 CARTON (46708-541-10) · 46708-541-10
- 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-541-17) · 46708-541-17
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-541-30) · 46708-541-30
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-541-31) · 46708-541-31
- 80 TABLET, EXTENDED RELEASE in 1 CARTON (46708-541-80) · 46708-541-80
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-541-90) · 46708-541-90
- 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-541-91) · 46708-541-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →